Emerald Advisers, LLC
- SEC CIK
- 0001015083
- Latest filing
- Aug 5, 2026
ANIP holding history
Ani Pharmaceuticals Inc in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANIP overviewAll 13F holders of ANIPFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,256
- Value
- $104.0K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,256 | $104.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,256 | $96.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,256 | $99.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,256 | $115.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,256 | $82.0K | <0.1% | +1,012+414.8% | Added | Holders |
| Q1 2025 | 244 | $16.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 244 | $13.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 244 | $14.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 244 | $15.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 244 | $16.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 244 | $13.5K | <0.1% | −174,033−99.9% | Reduced | Holders |
| Q3 2023 | 174,277 | $10.1M | 0.5% | +10.0% | Added | Holders |
| Q2 2023 | 174,276 | $9.38M | 0.4% | −199,130−53.3% | Reduced | Holders |
| Q1 2023 | 373,406 | $14.8M | 0.7% | −69,830−15.8% | Reduced | Holders |
| Q4 2022 | 443,236 | $17.8M | 0.9% | −13,512−3.0% | Reduced | Holders |
| Q3 2022 | 456,748 | $14.7M | 0.8% | +868+0.2% | Added | Holders |
| Q2 2022 | 455,880 | $13.5M | 0.7% | +101,835+28.8% | Added | Holders |
| Q1 2022 | 354,045 | $9.95M | 0.4% | +271,101+326.8% | Added | Holders |
| Q4 2021 | 82,944 | $3.82M | 0.1% | +82,944 | New | Holders |